Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Cited by (1,000)

Items 601–700 of 1,000

1. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches
   Jyotisha, Samayaditya Singh, Insaf Ahmed Qureshi · 2020 · Journal of Biomolecular Structure and Dynamics
2. Genome-scale CRISPR screen identifies TMEM41B as a multi-function host factor required for coronavirus replication
   Limeng Sun, Changzhi Zhao, Zhen Fang Fu, Yanan Fu, Zhelin Su, Yangyang Li, Yuan Zhou, Yubei Tan, Jingjin Li, Yixin Xiang et al. · 2021 · PLoS Pathogens
3. Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors
   Jalal Taneera, Waseem El‐Huneidi, Mawieh A. Hamad, Abdul Khader Mohammed, Esraa Elaraby, Mahmood Yaseen Hachim · 2020 · Biology
4. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies
   Lúcio Ricardo Leite Diniz, Yunierkis Pérez‐Castillo, Hatem A. Elshabrawy, Carlos da Silva Maia Bezerra Filho, Damião Pergentino de Sousa · 2021 · Biomolecules
5. Early and late endocrine complications of COVID-19
   Paraskevi Kazakou, Stavroula Α. Paschou, Θεοδώρα Ψαλτοπούλου, Maria Gavriatopoulou, Eleni Korompoki, Katerina Stefanaki, Fotini Kanouta, Georgia Kassi, Meletios Athanasios Dimopoulos, Asimina Mitrakou · 2021 · Endocrine Connections
6. Middle East respiratory syndrome coronavirus: a comprehensive review
   Mahmoud Shehata, Mokhtar R. Gomaa, Mohamed A. Ali, Ghazi Kayali · 2016 · Frontiers of Medicine
7. Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection
   Yufei Wang, Wanbo Tai, Jie Yang, Guangyu Zhao, Shihui Sun, Chien-Te Kent Tseng, Shibo Jiang, Yusen Zhou, Lanying Du, Jimin Gao · 2017 · Human Vaccines & Immunotherapeutics
8. Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016
   Mohamed A. Ali, Rabeh El‐Shesheny, Ahmed Kandeil, Mahmoud Shehata, Basma Elsokary, Mokhtar R. Gomaa, N. Hassan, Ahmed E. Kayed, Ahmed El Taweel, Heba Sobhy et al. · 2017 · Eurosurveillance
9. Current development of COVID-19 diagnostics, vaccines and therapeutics
   Naru Zhang, Chaoqun Li, Yue Hu, Kangchen Li, Jintian Liang, Lili Wang, Lanying Du, Shibo Jiang · 2020 · Microbes and Infection
10. Cell and animal models of SARS-CoV-2 pathogenesis and immunity
    Sarah R. Leist, Alexandra Schäfer, David R. Martinez · 2020 · Disease Models & Mechanisms
11. Potential Effects of Coronaviruses on the Liver: An Update
    Xinyi Wang, Jianyong Lei, Zhihui Li, Lünan Yan · 2021 · Frontiers in Medicine
12. Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19
    M. Abd Elkodous, Samuel Oluwaseun Olojede, Mahmoud Morsi, Gharieb Saied El-Sayyad · 2021 · RSC Advances
13. GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art
    Granata, Antonio, Maccarrone, Rosario, Anzaldi, Massimiliano, Leonardi, Giuseppe, Pesce, Francesco, Amico, Francesco, Gesualdo, Loreto, Corrao, Salvatore · 2022 · Clinical Kidney Journal
14. Middle East respiratory syndrome and severe acute respiratory syndrome
    Rahul Vijay, Stanley M. Perlman · 2016 · Current Opinion in Virology
15. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection
    Hongjie Qiu, Shihui Sun, Xiao He, Jiannan Feng, Yan Guo, Wanbo Tai, Yufei Wang, Lanying Du, Guangyu Zhao, Yusen Zhou · 2016 · Antiviral Research
16. CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
    Shuliang Chen, Xiao Yu, Deyin Guo · 2018 · Viruses
17. COVID-19 and diabetes: What does the clinician need to know?
    Eleni Papadokostaki, Nikolaοs Tentolouris, Evangelos N. Liberopoulos · 2020 · Primary care diabetes
18. Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns
    Chrysi C. Koliaki, Anastasios Tentolouris, Ioanna Eleftheriadou, Andreas J. Melidonis, George Dimitriadis, Nikolaοs Tentolouris · 2020 · Journal of Clinical Medicine
19. Development of Small-Molecule MERS-CoV Inhibitors
    Ruiying Liang, Lili Wang, Naru Zhang, Xiaoqian Deng, Meng Su, Yudan Su, Lanfang Hu, Chen He, Tianlei Ying, Shibo Jiang et al. · 2018 · Viruses
20. Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function
    R. Clayton Edenfield, Charles A. Easley · 2021 · Nature Reviews Urology
21. COVID-19 induced Diabetes: A novel presentation
    Samruddhi Chandrashekhar Joshi, Paolo Pozzilli · 2022 · Diabetes Research and Clinical Practice
22. Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses
    Clayton J. Otter, Alejandra Fausto, Li Hui Tan, Alisha S. Khosla, Noam A. Cohen, Susan Reich Weiss · 2023 · Proceedings of the National Academy of Sciences
23. Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia
    Doreen Muth, Victor M. Corman, Benjamin Meyer, Abdullah Mufareh Assiri, Malak M. Almasri, Mohamed Elamin Farah, Katja Steinhagen, Erik Lattwein, Jaffar A. Al‐Tawfiq, Ali M. Albarrak et al. · 2015 · Journal of Clinical Microbiology
24. Emergence of the Middle East Respiratory Syndrome Coronavirus
    Christopher M. Coleman, Matthew B. Frieman · 2013 · PLoS Pathogens
25. Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone
    W. Michael Dismuke, Mikael Klingeborn, William Daniel Stamer · 2016 · PLoS ONE
26. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection
    Kun Li, Zhuo Ya Li, Christine Wohlford-Lenane, David Kyle Meyerholz, Rudragouda Channappanavar, Dong An, Stanley M. Perlman, Paul B. McCray, Biao He · 2020 · mBio
27. Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV)
    Qiang Huang, Andreas Herrmann · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
28. Coronavirus Pandemic—Therapy and Vaccines
    Kenneth H. Lundstrom · 2020 · Biomedicines
29. Cardiovascular disease and COVID-19: les liaisons dangereuses
    Andrea Barison, Alberto Aimo, Vincenzo Castiglione, Chiara Arzilli, Josep Lupón, Pau Codina, Evelyn Santiago‐Vacas, Germán Cediel, Michele Emdin, Antoni Bayés‐Genís · 2020 · European Journal of Preventive Cardiology
30. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century
    Purva Asrani, Gulam Mustafa Hasan, Sukhwinder Singh Sohal, Md. Imtaiyaz Hassan · 2020 · OMICS A Journal of Integrative Biology
31. Identification of the immunodominant neutralizing regions in the spike glycoprotein of porcine deltacoronavirus
    Rui Chen, Jiayu Fu, Jingfei Hu, Cheng Li, Yujia Zhao, Huan Qu, Xintian Wen, Sanjie Cao, Yiping Wen, Rui Jin Wu et al. · 2019 · Virus Research
32. Angiotensin-converting Enzyme 2–containing Small Extracellular Vesicles and Exomeres Bind the Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
    Qin Zhang, Dennis K. Jeppesen, James N. Higginbotham, Jeffrey L. Franklin, James E. Crowe, Robert J. Coffey · 2020 · Gastroenterology
33. Blocking of Exchange Proteins Directly Activated by cAMP Leads to Reduced Replication of Middle East Respiratory Syndrome Coronavirus
    Xinrong Tao, Feng Mei, Anurodh Shankar Agrawal, Clarence J. Peters, Thomas G. Ksiazek, Xiaodong Cheng, Chien-Te Kent Tseng · 2014 · Journal of Virology
34. Membrane ectopeptidases targeted by human coronaviruses
    Berend‐Jan Bosch, Saskia L. Smits, Bart L. Haagmans · 2014 · Current Opinion in Virology
35. Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins—An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic
    Mingjia Yu, Tianji Zhang, Wei Zhang, Qianyun Sun, Hongmei Li, Jin‐Ping Li · 2021 · Frontiers in Molecular Biosciences
36. Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes
    Chunyan Wang, Emma L. Hesketh, Tatiana M. Shamorkina, Wentao Li, Peter J. Franken, Dubravka Drabek, Rien van Haperen, Sarah Townend, Frank J. M. van Kuppeveld, Frank G. Grosveld et al. · 2022 · Nature Communications
37. Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
    Lin Wang, Ye Xiang · 2020 · Viruses
38. Exceptional diversity and selection pressure on coronavirus host receptors in bats compared to other mammals
    Hannah K. Frank, David Enard, Scott Dexter Boyd · 2022 · Proceedings of the Royal Society B Biological Sciences
39. Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
    Jaffar A. Al‐Tawfiq, Ziad Ahmed Memish · 2016 · Expert Review of Anti-infective Therapy
40. Tissue Distribution of the MERS-Coronavirus Receptor in Bats
    W. Widagdo, Lineke Begeman, Debby Schipper, Peter R. van Run, Andrew A. Cunningham, Nils Kley, Chantal B. E. M. Reusken, Bart L. Haagmans, Judith M. A. van den Brand · 2017 · Scientific Reports
41. Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques
    Joseph B. Prescott, Darryl Falzarano, Emmie de Wit, Kath Hardcastle, Friederike Feldmann, Elaine Haddock, Dana P. Scott, Heinz Feldmann, Vincent Jacobus Munster · 2018 · Frontiers in Immunology
42. Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
    Nabab Khan, Xuesong Chen, Jonathan D. Geiger · 2020 · Frontiers in Pharmacology
43. SARS-CoV-2 (COVID-19) and the Endocrine System
    Michelle Diane Lundholm, Caroline A Poku, Nicholas Emanuele, Mary Ann Emanuele, Norma Lopez · 2020 · Journal of the Endocrine Society
44. The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis
    Yuki Hayashi, Kohei Wagatsuma, Masanori Nojima, Tsukasa Yamakawa, Tadashi Ichimiya, Yoshihiro Yokoyama, Tomoe Kazama, Daisuke Hirayama, Hiroshi Nakase · 2021 · Journal of Gastroenterology
45. Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection
    Anurodh Shankar Agrawal, Tianlei Ying, Xinrong Tao, Tania M. Garron, Abdullah A. Algaissi, Yanping Wang, Lili Wang, Bi‐Hung Peng, Shibo Jiang, Dimiter Stanchev Dimitrov et al. · 2016 · Scientific Reports
46. Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
    Mohamad Hesam Shahrajabian, Wenli Sun, Qi Cheng · 2020 · Human Vaccines & Immunotherapeutics
47. DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis
    Yan Yang, Zixin Cai, Jingjing Zhang · 2021 · PLoS ONE
48. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
    Karthika Thankamani, Jeswin Joseph, V.R. Akshay Das, Niranjana Nair, Packirisamy Charulekha, Melvin Daniel Roji, Victor Stalin Raj · 2021 · Cells
49. ACE2 and COVID-19 Susceptibility and Severity
    Ming Zheng · 2022 · Aging and Disease
50. Mechanisms of COVID-19 pathogenesis in diabetes
    Chandrakala Aluganti Narasimhulu, Dinender Kumar Singla · 2022 · American Journal of Physiology-Heart and Circulatory Physiology
51. Human coronavirus HKU1 recognition of the TMPRSS2 host receptor
    Matthew McCallum, Young‐Jun Park, Cameron Stewart, Kaitlin R. Sprouse, Amin Addetia, Jack T Brown, M. Alejandra Tortorici, Cecily A. Gibson, Emily Wong, Margareta M. Ieven et al. · 2024 · Cell
52. Determining the Replication Kinetics and Cellular Tropism of Influenza D Virus on Primary Well-Differentiated Human Airway Epithelial Cells
    Melle Holwerda, Jenna Nicole Kelly, Laura Laloli, Isabel Stürmer, Jasmine Portmann, Hanspeter Stalder, Ronald Dijkman · 2019 · Viruses
53. SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities
    Marcin Filip Osuchowski, Federico Mario Aletti, Jean‐Marc Cavaillon, Stefanie B. Flohé, Evangelos J. Giamarellos‐Bourboulis, Markus Stefan Huber-Lang, Borna Relja, Tomasz Skirecki, Andrea Szabó, Marc Maegele · 2020 · Shock
54. Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community
    Zichao Luo, Melgious Jin Yan Ang, Siew Yin Chan, Zhigao Yi, Yi Yiing Goh, Shuangqian Yan, Jun Tao, Kai Liu, Xiaosong Li, Hongjie Zhang et al. · 2020 · Research
55. Viral, host and environmental factors that favor anthropozoonotic spillover of coronaviruses: An opinionated review, focusing on SARS-CoV, MERS-CoV and SARS-CoV-2
    Priscilla Gomes da Silva, João R. Mesquita, Maria de São José Nascimento, Vanessa Andreia Martins Ferreira · 2020 · The Science of The Total Environment
56. An Overview of the Crystallized Structures of the SARS-CoV-2
    Mihaela Ileana Ionescu · 2020 · The Protein Journal
57. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
    Tiziana Filardi, Susanna Morano · 2020 · Journal of Endocrinological Investigation
58. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis
    Chao Quan, Caiyan Li, Han Ma, Yisha Li, Huali Zhang · 2020 · Clinical Microbiology Reviews
59. Human Coronavirus Infections—Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and SARS-CoV-2
    David S.C. Hui, Esam I. Azhar, Ziad Ahmed Memish, Alimuddin I. Zumla · 2020 · Elsevier eBooks
60. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections
    Ahmed-Hassan, Hanaa, Sisson, Brianna, Shukla, Rajni Kant, Wijewantha, Yasasvi, Funderburg, Nicholas T., Li, Zihai, Hayes, Don, Demberg, Thorsten, Liyanage, Namal P. M. · 2020 · Frontiers in Immunology
61. Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates
    Christian Selinger, Jennifer Tisoncik-Go, Vineet D. Menachery, Sudhakar Agnihothram, G. Lynn Law, Jean Chang, Sara M. Kelly, Pavel Sova, Ralph Steven Baric, Michael G. Katze · 2014 · BMC Genomics
62. Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus
    Fahad M. Al-Hameed · 2017 · Saudi Medical Journal
63. A Human DPP4-Knockin Mouse’s Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV
    Changfa Fan, Xi Wu, Qiang Liu, Qianqian Li, Susu Liu, Jianjun Lu, Yanwei Yang, Yuan Cao, Weijin Huang, Chunnan Liang et al. · 2018 · Viruses
64. Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms
    Ιoannis Ilias, Lina Zabulienė · 2020 · Medical Hypotheses
65. Neurobiology of coronaviruses: Potential relevance for COVID-19
    Mauro Cataldi, Giuseppe Pignataro, Maurizio Taglialatela · 2020 · Neurobiology of Disease
66. Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses
    Chengbao Ma, Chen Liu, Young‐Jun Park, Jingjing Tang, Jing Chen, Qing Xiong, Jimin Lee, Cameron Stewart, Daniel E. Asarnow, Jack T Brown et al. · 2025 · Cell
67. Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic
    Alejandro Llanes, Carlos Mario Restrepo, Zuleima Caballero E., Sreekumari Rajeev, Melissa A. Kennedy, Ricardo Lleonart · 2020 · International Journal of Molecular Sciences
68. Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
    Maike Sperk, Robert van Domselaar, Jimmy Rodriguez Murillo, Flora Mikaeloff, Beatriz Sá Vinhas, Elisa Saccon, Anders B. Sönnerborg, Kamal Deep Singh, Soham Gupta, Ákos Végvári et al. · 2020 · Journal of Proteome Research
69. Naturally Occurring Animal Coronaviruses as Models for Studying Highly Pathogenic Human Coronaviral Disease
    Scott P. Kenney, Qiuhong Wang, Anastasia Nickolaevna Vlasova, Kwonil Jung, Linda J. Saif · 2020 · Veterinary Pathology
70. Isolation of MERS-related coronavirus from lesser bamboo bats that uses DPP4 and infects human-DPP4-transgenic mice
    Susanna K. P. Lau, Rachel Y. Y. Fan, Longchao Zhu, Kenneth S. M. Li, Antonio C. P. Wong, Hayes K. H. Luk, Emily Y. M. Wong, Carol S. F. Lam, George Chi-Shing Lo, Joshua Fung et al. · 2021 · Nature Communications
71. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species
    Hong-Liang Zhang, Yuming Li, Jing Sun, Yu-Yuan Zhang, Tong-Yun Wang, Ming-xia Sun, Meng-Hang Wang, Yue-Lin Yang, Xiao-Liang Hu, Yan‐Dong Tang et al. · 2021 · Journal of Biological Chemistry
72. Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems
    Ahmed A. Abd El‐Latif, Hesham M. Tawfeek, Ahmed M. Abdelfattah, Gaber El‐Saber Batiha, ‏Helal F. Hetta · 2021 · Journal of Drug Delivery Science and Technology
73. Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?
    Roger Yazbeck, Simone E. Jaenisch, Catherine Anne Abbott · 2021 · Biochemical Pharmacology
74. Angiotensin‐converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection
    Heng Wee Tan, Yan‐Ming Xu, Andy T. Y. Lau · 2020 · Reviews in Medical Virology
75. Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses
    Young‐Jun Park, Chen Liu, Jimin Lee, Jack T Brown, Chengbao Ma, Peng Liu, Risako Gen, Qing Xiong, Samantha K. Zepeda, Cameron Stewart et al. · 2025 · Cell
76. Targeting protein-protein interaction interfaces in COVID-19 drug discovery
    Chung‐ke Chang, Shanmeng Lin, Roshan Satange, Shih‐Chao Lin, Sin-Cih Sun, Hung‐Yi Wu, Kylene Kehn‐Hall, Ming‐Hon Hou · 2021 · Computational and Structural Biotechnology Journal
77. SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses
    George Carnell, Katarzyna A. Ciazynska, David A. Wells, Xiaoli Xiong, Ernest T. Aguinam, Stephen H. McLaughlin, Donna L. Mallery, Soraya Ebrahimi, Lourdes Ceron‐Gutierrez, Benedikt Asbach et al. · 2021 · Journal of Virology
78. Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases
    Xinling Wang, Shuai Xia, Qian Wang, Wei Xu, Weihua Li, Lu Lu, Shibo Jiang · 2020 · International Journal of Molecular Sciences
79. Endocrine Conditions and COVID-19
    Skand Shekhar, Rachel Wurth, Crystal Dawn Chrysavgi Kamilaris, Graeme Eisenhofer, Francisco J. Barrera, Michelle Hajdenberg, Joselyne Tessa Tonleu, Janet Elizabeth Hall, Ernesto L. Schiffrin, Forbes D. Porter et al. · 2020 · Hormone and Metabolic Research
80. Middle East respiratory syndrome novel corona MERS-CoV infection. Epidemiology and outcome update
    Jaffar A. Al‐Tawfiq, Abdullah Mufareh Assiri, Ziad Ahmed Memish · 2013 · Saudi Medical Journal
81. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection
    Wenxu Jia, Rudragouda Channappanavar, Chao Zhang, Mingxi Li, Haixia Zhou, Shuyuan Zhang, Pan-Pan Zhou, Jiuyang Xu, Sisi Shan, Xuanling Shi et al. · 2019 · Emerging Microbes & Infections
82. A Novel Bacterium-Like Particle Vaccine Displaying the MERS-CoV Receptor-Binding Domain Induces Specific Mucosal and Systemic Immune Responses in Mice
    Entao Li, Hang Chi, Pei Huang, Feihu Yan, Ying Zhang, Chuanyu Liu, Zhenshan Wang, Guohua Li, Shengnan Zhang, Ruo Mo et al. · 2019 · Viruses
83. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
    Cristina Cerqueira Vieira, Lucas Nery, Ludimila de Barcelos Ubaldo Martins, Luiz Gustavo Pessoa Pires Jabour, Raphael Figuiredo Dias, Ana Cristina Simões e Silva · 2020 · Current Drug Targets
84. Translational adaptation of human viruses to the tissues they infect
    Xavier Hernandez‐Alias, Hannah Benisty, Martin H. Schaefer, Luis G. Serrano · 2021 · Cell Reports
85. Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview
    Rukmankesh Mehra, Kasper P. Kepp · 2021 · ACS Infectious Diseases
86. A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective
    Ali Ahmed Rabaan, Shamsah H. Al-Ahmed, Ali M. Bazzi, Hatem M. Alhani · 2017 · Journal of Medical Microbiology
87. Expression of SARS-CoV-2 entry factors in lung epithelial stem cells and its potential implications for COVID-19
    Anna A. Valyaeva, Anastasia A. Zharikova, Artem S. Kasianov, Yegor S Vassetzky, Eugene V. Sheval · 2020 · Scientific Reports
88. Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis
    Jinjing Wei, Ruxin Wang, Haowen Ye, Ying Wang, Lihong Wang, Xiaofang Zhang · 2022 · Frontiers in Endocrinology
89. SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147
    Shaimaa Shouman, Nada Elkholy, Alaa E. Hussien, Azza M. El-Derby, Shireen Magdy, Ahmed M. Abou‐Shanab, Ahmed Osama Elmehrath, Ahmad Abdelwaly, Mohamed A. Helal, Nagwa El‐Badri · 2024 · Cell Communication and Signaling
90. Emerging infectious diseases associated with bat viruses
    ZhengLi Shi · 2013 · Science China Life Sciences
91. Advances in antivirals for non‐influenza respiratory virus infections
    Frederick G. Hayden · 2013 · Influenza and Other Respiratory Viruses
92. Genomic Analysis of the Emergence, Evolution, and Spread of Human Respiratory RNA Viruses
    Tommy Tsan‐Yuk Lam, Huachen Zhu, Yi Guan, Edward Charles Holmes · 2016 · Annual Review of Genomics and Human Genetics
93. Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants
    Kayla M. Peck, Trevor Scobey, Jesica Swanstrom, Kara Jensen, Christina L. Burch, Ralph Steven Baric, Mark T. Heise · 2017 · Journal of Virology
94. Novel Alphacoronaviruses and Paramyxoviruses Cocirculate with Type 1 and Severe Acute Respiratory System (SARS)-Related Betacoronaviruses in Synanthropic Bats of Luxembourg
    Maude Pauly, Jacques B. Pir, Catherine Loesch, Aurélie Sausy, Chantal J. Snoeck, Judith M. Hübschen, Claude P. Muller · 2017 · Applied and Environmental Microbiology
95. Genomic analysis and comparative multiple sequences of SARS-CoV2
    Tai-Jay Chang, De‐Ming Yang, Mong‐Lien Wang, Kung-How Liang, Ping‐Hsing Tsai, Shih-Hwa Chiou, Ta‐Hsien Lin, Chin-Tien Wang · 2020 · Journal of the Chinese Medical Association
96. COVID-19: Impact of and on Diabetes
    Jonathan D. Schofield, Lalantha Leelarathna, Hood Thabit · 2020 · Diabetes Therapy
97. Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
    Peigang Wang, Dongjiang Tang, Zhan Hua, Zai Wang, Jing An · 2020 · Cell Discovery
98. Exogenous Coronavirus Interacts With Endogenous Retrotransposon in Human Cells
    Ying Yin, Xiaozhao Liu, Ximiao He, Liquan Zhou · 2021 · Frontiers in Cellular and Infection Microbiology
99. Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
    Alba Sebastián-Martín, Belén G. Sánchez, José María Mora-Rodríguez, Alicia Bort, Inés Díaz‐Laviada · 2022 · Biomedicines
100. How lessons learned from the 2015 Middle East respiratory syndrome outbreak affected the response to coronavirus disease 2019 in the Republic of Korea
     Tae Un Yang, Ji Yun Noh, Joon Young Song, Hee Jin Cheong, Woo Joo Kim · 2020 · The Korean Journal of Internal Medicine